Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumonia in the elderly.

Mark Loeb1

  • 1Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. loebm@mcmaster.ca

Current Opinion in Infectious Diseases
|March 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibiotic prescribing for aspiration pneumonia in the intensive care unit.

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada·2026
Same author

Antimicrobial Resistance (AMR) Consequences of the use of Doxycycline for Prevention of Bacterial Sexually Transmitted Infections (STIs): A Systematic Review.

Sexually transmitted diseases·2026
Same author

Use of administrative data for evaluating trends in medically-attended Lyme disease, Manitoba, Canada, 2010-2021.

PloS one·2026
Same author

Populations at Risk for Severe or Complicated Rhinovirus Illness: A Systematic Review and Meta-Analysis.

Influenza and other respiratory viruses·2026
Same author

Antibiotic Prophylaxis Strategies and Surgical Site Infections in Colorectal Surgery: A Systematic Review and Network Meta-Analysis.

JAMA network open·2026
Same author

Macrolides for asthma: A systematic review and meta-analysis of randomized trials.

The Journal of allergy and clinical immunology·2026
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Community-acquired pneumonia in the elderly is often caused by Streptococcus pneumoniae and presents with nonspecific symptoms. Continued support for pneumococcal polysaccharide vaccines is recommended, alongside research into novel vaccine strategies.

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Public Health

Background:

  • Community-acquired pneumonia (CAP) presents unique challenges in elderly populations.
  • Older adults are at increased risk for severe complications and mortality from pneumonia.

Purpose of the Study:

  • To review current data on the etiology, clinical features, outcomes, and prevention of CAP in the elderly.
  • To address the impact of severe acute respiratory syndrome (SARS) on older individuals.

Main Methods:

  • Comprehensive literature review of recent studies on CAP in the elderly.
  • Analysis of data on vaccine efficacy and clinical presentation in older adults.

Main Results:

  • Streptococcus pneumoniae is the primary cause of CAP in individuals aged 80 and over and in long-term care facilities.

Related Experiment Videos

  • Clinical symptoms of CAP are often less distinct in the very elderly.
  • Influenza vaccine data suggest better mucosal immunity with intranasal administration.
  • Observational studies support the benefit of polysaccharide pneumococcal vaccine in the elderly, contrasting with some clinical trial evidence.
  • Severe acute respiratory syndrome (SARS) poses a significant emerging threat to older adults.

    • Conclusions:

    • Preventing and managing CAP in the elderly requires addressing challenges like nonspecific clinical presentation and the persistent role of S. pneumoniae.
    • Public health policy should support the polysaccharide pneumococcal vaccine due to its safety and observational evidence of benefit.
    • Prioritizing research into new vaccine strategies, such as conjugate or common antigen vaccines, is crucial.